Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 -0.04 (-3.39%)
As of: Sep 29, 2026 · 3:59 PM EDT

Actinium Pharmaceuticals (ATNM) Share-based Compensation (2012 - 2026)

Updated

Actinium Pharmaceuticals (ATNM) reported Share-based Compensation of $118,000 for Q2 2026, down 40.1% from $197,000 a year earlier but up 972.7% from the prior quarter.

Analysis

Actinium Pharmaceuticals (ATNM) Share-based Compensation (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Actinium Pharmaceuticals' Share-based Compensation came in at $248,000, down 97.9% year-over-year; for FY2025, it came in at $9.19 million, up 73.7% from FY2024.

  • Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 48.9% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $5.29 million in FY2024 (+37.7%), $3.84 million in FY2023 (+37.5%), $2.8 million in FY2022 (+65.0%) and $1.69 million in FY2021 (+35.1%).
  • Five-year quarterly Share-based Compensation spans a low of $10,000 in Q4 2025 and a high of $8.87 million in Q1 2025.
  • Year over year, Share-based Compensation has now declined in each of the last five quarters, with growth averaging 25.3% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q1 2025 (growth of 544.0%); the low point was Q1 2026 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $11,000 (Q1 2026), $10,000 (Q4 2025) and $109,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - 118,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118,000.00
Mar 31, 2026 11,000.00
Dec 31, 2025 10,000.00
Sep 30, 2025 109,000.00
Jun 30, 2025 197,000.00
Mar 31, 2025 8.87 Mn
Dec 31, 2024 1.20 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.37 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 927,000.00
Sep 30, 2023 921,000.00
Jun 30, 2023 1.00 Mn
Mar 31, 2023 993,000.00
Dec 31, 2022 979,000.00
Sep 30, 2022 970,000.00
Jun 30, 2022 425,000.00
Mar 31, 2022 421,000.00
Dec 31, 2021 448,000.00
Sep 30, 2021 411,000.00
API Access

Actinium Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATNM&period=max&api_key=YOUR_API_KEY